more on intellectual property... (fortune.com)

submitted 5 months ago by anzo@programming.dev to c/piracy@lemmy.dbzer0.com

17 comments fedilink hide all child comments

cross-posted from: https://mander.xyz/post/11304633

Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5

you are viewing a single comment's thread
view the rest of the comments

[-] seriousconsideration@lemmy.dbzer0.com 3 points 5 months ago* (last edited 5 months ago)

You're probably right. It's more than likely the cost per dose. Which is also what the $1000 figure represents.

The Vermont independent (Bernie) called on Novo Nordisk to lower the list price of Ozempic to $155 a month or less, in line with what it charges in other countries.

Somehow they can justify selling it for $155 a dose (per month?) in other countries while still making a profit above the overhead and compliance costs.